ARTICLE | Company News
Cyclacel, ManRos Therapeutics deal
August 3, 2015 7:00 AM UTC
Cyclacel granted ManRos exclusive, worldwide rights to develop and commercialize oral seliciclib capsules to treat cystic fibrosis (CF). Cyclacel will receive an upfront payment and is eligible to receive milestones and tiered royalties. Cyclacel will provide its clinical data and technical assistance and supply the product to ManRos for clinical trials. ...